Literature DB >> 20615672

The impact of premenstrual dysphoric disorder among 92 bipolar patients.

M Fornaro1, G Perugi.   

Abstract

OBJECTIVES: To evaluate the impact of Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV)-defined premenstrual dysphoric disorder (PMDD) lifetime co-morbidity among 92 bipolar patients.
METHOD: Ninety-two women with a lifetime diagnosis of DSM-IV-defined Bipolar Disorder (BD) either type I or type II were consecutively enrolled to determine co-morbidity rates with PMDD and associated clinical features. Measures included the Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I) and the Clinical Global Impression (CGI) rating scale.
RESULTS: In our sample, 25 (27.2%) patients reported a lifetime history of PMDD according to DSM-IV criteria (PMDD+). PMDD+ reported higher rates of Cyclothymia and BP-II than PMDD- (respectively 72% vs. 36% and 88% vs. 60%). On the contrary, the carbohydrate-craving feature was more represented among PMDD- than PMDD+ (25% vs. 4%). PMDD was also significantly associated with post-partum depression (36% vs. 15%), Obsessive-Compulsive (24% vs. 7.5%) and Body Dysmorphic Disorders (24% vs. 6%). Finally, PMDD+ reported higher total number of Axis I co-morbid disorders than PMDD-.
CONCLUSIONS: In our cohort of BD women, PMDD is a frequent co-morbid condition, in particular among patients with BD-II or Cyclothymia. Multiple co-morbidities also represent a clinical variable associated with PMDD. Further perspective studies are necessary to better define the relationships between PMDD and BD.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20615672     DOI: 10.1016/j.eurpsy.2009.11.010

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  8 in total

1.  Treating comorbid premenstrual dysphoric disorder in women with bipolar disorder.

Authors:  Mara Smith; Benicio N Frey
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

2.  Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study.

Authors:  A Slyepchenko; B N Frey; B Lafer; A A Nierenberg; G S Sachs; R S Dias
Journal:  Acta Psychiatr Scand       Date:  2017-08-28       Impact factor: 6.392

3.  Resting-state functional connectivity in individuals with bipolar disorder during clinical remission: a systematic review.

Authors:  Sabrina K Syan; Mara Smith; Benicio N Frey; Raheem Remtulla; Flavio Kapczinski; Geoffrey B C Hall; Luciano Minuzzi
Journal:  J Psychiatry Neurosci       Date:  2018-08       Impact factor: 6.186

Review 4.  Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence.

Authors:  Elena Aragno; Andrea Fagiolini; Alessandro Cuomo; Elena Paschetta; Giuseppe Maina; Gianluca Rosso
Journal:  Arch Womens Ment Health       Date:  2022-03-02       Impact factor: 3.633

5.  Age at Menarche in Women With Bipolar Disorder: Correlation With Clinical Features and Peripartum Episodes.

Authors:  Gianluca Rosso; Elena Aragno; Emina Mehanović; Gabriele Di Salvo; Giuseppe Maina
Journal:  Front Psychiatry       Date:  2020-09-04       Impact factor: 4.157

6.  Relationship of premenstrual syndrome and premenstrual dysphoric disorder with major depression: relevance to clinical practice.

Authors:  Susanta Kumar Padhy; Sidharth Sarkar; Prakash B Beherre; Rajesh Rathi; Mahima Panigrahi; Pradeep Sriram Patil
Journal:  Indian J Psychol Med       Date:  2015 Apr-Jun

7.  Brain Structure and Function in Women with Comorbid Bipolar and Premenstrual Dysphoric Disorder.

Authors:  Sabrina K Syan; Luciano Minuzzi; Mara Smith; Dustin Costescu; Olivia R Allega; Geoffrey B C Hall; Benicio N Frey
Journal:  Front Psychiatry       Date:  2018-01-10       Impact factor: 4.157

Review 8.  Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges.

Authors:  Gianna Sepede; Marcella Brunetti; Massimo Di Giannantonio
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-10       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.